Clinical Trials Directory

Trials / Completed

CompletedNCT06398821

G3P-01 in Volunteers With Elevated Galectin-3

A Dose Ranging Target Engagement Study of a Food-Grade Pectic Food Supplement (G3P-01) in Volunteers With Elevated Levels of Galectin-3 - the Galaxy Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
48 (actual)
Sponsor
General Practitioners Research Institute · Network
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

G3P-01 is an investigational pectin extracted, enriched and purified from commercial squash puree intended for human consumption. Pectins are an important constituent of fruits and vegetables, and health benefits are attributed to its intake. Some of the health benefits of pectins are attributed to inhibition of galectin-3. This study investigates if 30-days of G3P-01 intake in individuals with elevated galectin-3 induces biomarker changes that can be attributed to target engagement. Participants will be randomized into four groups (placebo, 100mg, 250mg and 1000mg G3P-01).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTG3P-01Nutritional supplement to promote healthy aging
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2023-10-18
Primary completion
2024-04-16
Completion
2024-05-30
First posted
2024-05-03
Last updated
2024-08-09

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06398821. Inclusion in this directory is not an endorsement.